Göttingen, Germany

Daria Onichtchouk

This inventor holds 1 USPTO granted patent and 1 published patent application and 6 EPO patents. Top assignee: Evotec International Gmbh. Active years: 2013.

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Daria Onichtchouk: Innovator in Pancreatic Disease Research

Introduction

Daria Onichtchouk is a prominent inventor based in Göttingen, Germany. She has made significant contributions to the field of medical research, particularly in the area of pancreatic diseases and metabolic disorders. Her innovative work has led to the development of a patent that addresses critical health issues.

Latest Patents

Daria holds a patent for the "Use of pleiotrophin for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome." This invention discloses the protein pleiotrophin secreted by the developing pancreas, along with polynucleotides that identify and encode this protein. The patent also relates to the use of these sequences in the diagnosis, study, prevention, and treatment of pancreatic diseases, such as diabetes, obesity, and metabolic syndrome. She has 1 patent to her name.

Career Highlights

Throughout her career, Daria has worked with notable companies in the biotechnology sector. She has been associated with Evotec International GmbH and Develogen Aktiengesellschaft, where she has contributed her expertise in research and development.

Collaborations

Daria has collaborated with several professionals in her field, including Ulrike Burk and Karsten Eulenberg. These collaborations have further enhanced her research and innovation efforts.

Conclusion

Daria Onichtchouk is a remarkable inventor whose work in pancreatic disease research has the potential to impact many lives. Her dedication to innovation and collaboration in the field of medical science is commendable.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…